Immunotherapy Against HPV16/18 Generates Potent T H 1 and Cytotoxic Cellular Immune Responses-Reference-Cited by-同舟云学术

Immunotherapy Against HPV16/18 Generates Potent T H 1 and Cytotoxic Cellular Immune Responses

Published:2012-10-10 Issue:155 Volume:4 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Bagarazzi Mark L.¹,Yan Jian¹,Morrow Matthew P.¹,Shen Xuefei¹,Parker R. Lamar²,Lee Jessica C.¹,Giffear Mary¹,Pankhong Panyupa³,Khan Amir S.¹,Broderick Kate E.¹,Knott Christine¹,Lin Feng¹,Boyer Jean D.³,Draghia-Akli Ruxandra¹,White C. Jo¹,Kim J. Joseph¹,Weiner David B.³,Sardesai Niranjan Y.¹

Affiliation:

1. Inovio Pharmaceuticals Inc., 1787 Sentry Parkway West, Building 18, Suite 400, Blue Bell, PA 19422, USA.

2. Lyndhurst Clinical Research, Winston-Salem, NC 27103, USA.

3. Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

Abstract

CD8 + T cells with cytolytic activity are induced after therapeutic human papillomavirus vaccination in humans.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference80 articles.

1. Global Cancer Statistics, 2002

2. Human papillomavirus and risk factors for cervical cancer in Chennai, India: A case-control study

3. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

4. Against which human papillomavirus types shall we vaccinate and screen? the international perspective

5. Human papillomavirus in cervical cancer

Cited by 258 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety, Efficacy, and Immunogenicity of Therapeutic Vaccines for Patients with High-Grade Cervical Intraepithelial Neoplasia (CIN 2/3) Associated with Human Papillomavirus: A Systematic Review;Cancers;2024-02-05

2. Advancing personalized medicine in brain cancer: exploring the role of mRNA vaccines;Journal of Translational Medicine;2023-11-18

3. Advances in Cancer Vaccine Research;ACS Biomaterials Science & Engineering;2023-11-03

4. Efficacy and safety of therapeutic HPV vaccines to treat CIN 2/CIN 3 lesions: a systematic review and meta-analysis of phase II/III clinical trials;BMJ Open;2023-10

5. The future of cancer immunotherapy: DNA vaccines leading the way;Medical Oncology;2023-06-09